retatrutide trial update ESC 2024: improves lipid and cardiovascular risk profile in Phase II Retatrutide, an investigational triple hormone

CG189 Full guideline (Appendix Q) recommendations from NICE guideline CG43 deleted or changed

Coverage varies by region, plan, and whether you meet certain criteria

If youd rather not have a pill or an injection, a transdermal patch may be a more comfortable option for taking some medications

Research suggests that L-Carnitine may contribute to improved endurance, reduced muscle soreness, and faster recovery, particularly in individuals engaging in regular or intense physical activity

Pierre Rojas, DO helps patients across Oakland County treat the deeper causes of bursitis through regenerative care that restores tissue, reduces inflammation, and protects long-term joint mobility

& Telser, J